Enhancement of flap survival and changes in angiogenic gene expression after AAV2-mediated VEGF gene transfer to rat ischemic flaps

Wound Repair and Regeneration

Volumn 19, Issue 4, 2011, Pages 498-504

  Wang, Xiao Tian ^a,b   Avanessian, Bella ^a,b   Ma, Qiangzhong ^a,b   Durfee, Heather ^a,b   Tang, Yu Qing ^a,b   Liu, Paul Y ^a,b  

^a BROWN UNIVERSITY   (United States)

^b BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENO ASSOCIATED VIRUS TYPE 2 VECTOR; COLLAGEN; CXCL1 CHEMOKINE; CXCL9 CHEMOKINE; ENDOGLIN; ENDOTHELIAL PAS DOMAIN PROTEIN 1; EPIDERMAL GROWTH FACTOR; EPIREGULIN; FIBROBLAST GROWTH FACTOR 2; GELATINASE B; GREEN FLUORESCENT PROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; PARVOVIRUS VECTOR; PLASMINOGEN; PLATELET DERIVED GROWTH FACTOR A; PROCOLLAGEN TYPE IV ALPHA 3; PROTHROMBIN; STROMAL CELL DERIVED FACTOR 1; T BOX 4 PROTEIN; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; VASCULOTROPIN; VASCULOTROPIN B;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE TRANSFER; IMMUNOHISTOCHEMISTRY; ISCHEMIA; NONHUMAN; PRIORITY JOURNAL; RAT; REAL TIME POLYMERASE CHAIN REACTION; SKIN BLOOD FLOW; SKIN FLAP SURVIVAL; UPREGULATION;

ANIMALS; DEPENDOVIRUS; DOWN-REGULATION; FEMALE; FIBROBLAST GROWTH FACTOR 2; GENE EXPRESSION PROFILING; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; GRAFT SURVIVAL; IMMUNOHISTOCHEMISTRY; ISCHEMIA; NEOVASCULARIZATION, PHYSIOLOGIC; PLATELET-DERIVED GROWTH FACTOR; POLYMERASE CHAIN REACTION; RATS; RATS, SPRAGUE-DAWLEY; SURGICAL FLAPS; UP-REGULATION; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR B;

EID: 79960096807     PISSN: 10671927     EISSN: 1524475X     Source Type: Journal    
DOI: 10.1111/j.1524-475X.2011.00705.x     Document Type: Article

References (34)

1. Taub PJ, Marmur JD, Zhang WX, Senderoff D, Nhat PD, Phelps R, Urken ML, Silver L, Weinberg H., Locally administered vascular endothelial growth factor cDNA increases survival of ischemic experimental skin flaps. Plast Reconstr Surg 1998; 102: 2033-9. (Pubitemid 28518529)
2. Neumeister MW, Song YH, Mowlavi A, Suchy H, Mathur A., Effects of liposome-mediated gene transfer of VEGF in ischemic rat gracillis muscle. Microsurgery 2001; 21: 58-62. (Pubitemid 32274073)
3. Fujihara Y, Koyama H, Nishiyama N, Eguchi T, Takato T., Gene transfer of bFGF to recipient bed improves survival of ischemic skin flap. Br J Plast Surg 2005; 58: 511-7. (Pubitemid 40645393)
4. Liu PY, Tong W, Liu K, Han SH, Wang XT, Badiavas E, Rieger-Christ K, Summerhayes I., Liposome-mediated transfer of vascular endothelial growth factor cDNA augments survival of random-pattern skin flaps in the rat. Wound Repair Regen 2004; 12: 80-5. (Pubitemid 38249138)
5. Liu PY, Wang XT, Badiavas E, Rieger-Christ K, Tang JB, Summerhayes I., Enhancement of ischemic flap survival by prefabrication with transfer of exogenous PDGF gene. J Reconstr Microsurg 2005; 21: 273-9. (Pubitemid 40721021)
6. Lubiatowski P, Goldman CK, Gurunluoglu R, Carnevale K, Siemionow M., Enhancement of epigastric skin flap survival by adenovirus-mediated VEGF gene therapy. Plast Reconstr Surg 2002; 109: 1986-93. (Pubitemid 34492428)
7. O'Toole G, MacKenzie D, Lindeman R, Buckley MF, Marucci D, McCarthy N, Poole M., Vascular endothelial growth gene therapy in ischemic rat skin flaps. Br J Plast Surg 2002; 55: 55-8. (Pubitemid 34071907)
8. Gurunluoglu R, Meirer R, Shafighi M, Huemer GM, Yilmaz B, Piza-Katzer H., Gene therapy with adenovirus-mediated VEGF enhances skin flap prefabrication. Microsurgery 2005; 25: 433-41.
9. Nakagawa A, Makino H, Aoki M, Miyake T, Shiraya S, Nakamura T, Ogihara T, Kimata Y, Morishita R., Improvement of survival of skin flaps by combined gene transfer of hepatocyte growth factor and prostacyclin synthase. J Gene Med 2007; 9: 1087-94. (Pubitemid 350286414)
10. Huang N, Khan A, Ashrafpour H, Neligan PC, Forrest CR, Kontos CD, Pang CY., Efficacy and mechanism of adenovirus-mediated VEGF-165 gene therapy for augmentation of skin flap viability. Am J Physiol Heart Circ Physiol 2006; 291: H127-37.
11. Goater J, Muller R, Kollias G, Firestein GS, Sanz I, O'Keefe RJ, Schwarz EM., Empirical advantages of adeno-associated viral vectors in vivo gene therapy for arthritis. J Rheumatol 2000; 27: 983-9. (Pubitemid 30389758)
12. Galeano M, Deodato B, Altavilla D, Cucinotta D, Arsic N, Marini H, Torre V, Giacca M, Squadrito F., Adeno-associated viral vector-mediated human vascular endothelial growth factor gene transfer stimulates angiogenesis and wound healing in the genetically diabetic mouse. Diabetologia 2003; 46: 546-55. (Pubitemid 36577800)
13. Gafni Y, Pelled G, Zilberman Y, Turgeman G, Apparailly F, Yotvat H, Galun E, Gazit Z, Jorgensen C, Gazit D., Gene therapy platform for bone regeneration using an exogenously regulated, AAV-2-based gene expression system. Mol Ther 2004; 9: 587-95. (Pubitemid 38578809)
14. Arsic N, Zacchigna S, Zentilin L, Ramirez-Correa G, Pattarini L, Salvi A, Sinagra G, Giacca M., Vascular endothelial growth factor stimulates skeletal muscle regeneration in vivo. Mol Ther 2004; 10: 844-54. (Pubitemid 39419911)
15. Cucchiarini M, Madry H, Ma C, Thurn T, Zurakowski D, Menger MD, Kohn D, Trippel SB, Terwilliger EF., Improved tissue repair in articular cartilage defects in vivo by rAAV-mediated overexpression of human fibroblast growth factor 2. Mol Ther 2005; 12: 229-38. (Pubitemid 41025092)
16. Monahan PE, Samulski RJ, Tazelaar J, Xiao X, Nichols TC, Bellinger DA, Read MS, Walsh CE., Direct intramuscular injection with recombinant AAV vectors results in sustained expression in a dog model of hemophilia. Gene Ther 1998; 5: 40-9. (Pubitemid 28045068)
17. Song S, Scott-Jorgensen M, Wang J, Poirier A, Crawford J, Campbell-Thompson M, Flotte TR., Intramuscular administration of recombinant adeno-associated virus 2 alpha-1 antitrypsin (rAAV-SERPINA1) vectors in a nonhuman primate model: safety and immunologic aspects. Mol Ther 2002; 6: 329-35. (Pubitemid 36305334)
18. Zhu B, Cao Y, Xin KQ, Summerhayes IC, Liu PY, Tang JB., Tissue reactions of adenoviral, adeno-associated viral, and liposome-plasmid vectors in tendons and comparison with early-stage healing responses of injured flexor tendons. J Hand Surg (Am) 2006; 31: 1652-60. (Pubitemid 44834571)
19. Zacchigna S, Papa G, Antonini A, Novati F, Moimas S, Carrer A, Arsic N, Zentilin L, Visintini V, Pascone M, Giacca M., Improved survival of ischemic cutaneous and musculocutaneous flaps after vascular endothelial growth factor gene transfer using adeno-associated virus vectors. Am J Pathol 2005; 167: 981-91. (Pubitemid 41416251)
20. Antonini A, Zacchigna S, Papa G, Novati F, Pascone M, Giacca M., Improved survival of rat ischemic cutaneous and musculocutaneous flaps after VEGF gene transfer. Microsurgery 2007; 27: 439-45. (Pubitemid 47255157)
21. Liu PY, Wang XT, Xin KQ, Chen CH, Rieger-Christ K, Summerhayes IC, Wu YF, Tang JB., Application of AAV2-mediated bFGF gene therapy on survival of ischemic flaps: effects of timing of gene transfer. Ann Plast Surg 2009; 62: 87-91.
22. Strieter RM, Burdick MD, Gomperts BN, Belperio JA, Keane MP., CXC chemokines in angiogenesis. Cytokine Growth Factor Rev 2005; 16: 593-609. (Pubitemid 41505519)
23. Dimberg A., Chemokines in angiogenesis. Curr Top Microbiol Immunol 2010; 341: 59-80.
24. Rundhaug JE., Matrix metalloproteinases and angiogenesis. J Cell Mol Med 2005; 9: 267-85.
25. Somanath PR, Razorenova OV, Chen J, Byzova TV., Akt1 in endothelial cell and angiogenesis. Cell Cycle 2006; 5: 512-8. (Pubitemid 43340529)
26. Livak KJ, Schmittgen TD., Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001; 25: 402-8. (Pubitemid 34164012)
27. Wolpe SD, Sherry B, Juers D, Davatelis G, Yurt RW, Cerami A., Identification and characterization of macrophage inflammatory protein 2. Proc Natl Acad Sci USA 1989; 86: 612-6. (Pubitemid 19037791)
28. Filion MC, Phillips NC., Toxicity and immunomodulatory activity of liposomal vectors formulated with cationic lipids toward immune effector cells. Biochim Biophys Acta 1997; 1329: 345-56. (Pubitemid 27466823)
29. Dokka S, Toledo D, Shi X, Castranova V, Rojanasakul Y., Oxygen radical-mediated pulmonary toxicity induced by some cationic liposomes. Pharm Res 2000; 17: 521-5. (Pubitemid 30416388)
30. Muruve DA., The innate immune response to adenovirus vectors. Hum Gene Ther 2004; 15: 1157-66. (Pubitemid 40052429)
31. Daya S, Berns KI., Gene therapy using adeno-associated virus vectors. Clin Microbiol 2008; 21: 583-93.
32. Coura Rdos S, Nardi NB., The state of the art of adeno-associated virus-based vectors in gene therapy. Virol J 2007; 4: 99.
33. Hengge UR, Mirmohammadsadegh A., Adeno-associated virus expresses transgenes in hair follicles and epidemis. Mol Ther 2000; 2: 188-94.
34. Donahue BA, McArthur JG, Spratt SK, Bohl D, Lagarde C, Sanchez L, Kaspar BA, Sloan BA, Lee YL, Danos O, Snyder RO., Selective uptake and sustained expression of AAV vectors following subcutaneous delivery. J Gene Med 1999; 1: 31-42. (Pubitemid 129631061)